Enterprise Products Partners Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Enterprise Products Partners (EPD) is set to report Q2 earnings on July 28, with analysts projecting flat EPS at $0.64 and revenue growth to $14.18 billion. The company recently issued $2.0 billion in senior notes. While EPD shares closed at $31.55, analyst sentiment is mixed; some firms like Mizuho, Barclays, and Citigroup have recently lowered their price targets, while JP Morgan and Morgan Stanley have raised theirs, indicating a varied but generally constructive outlook ahead of the results.

Analysis

Enterprise Products Partners (EPD) is approaching its second-quarter earnings release on July 28 with consensus estimates pointing to a diverging top and bottom-line performance. Analysts project quarterly earnings will remain flat year-over-year at $0.64 per share, which suggests potential margin stabilization or cost pressures that are offsetting an anticipated revenue increase to $14.18 billion from $13.48 billion. The company's balance sheet activity is notable, following a significant $2.0 billion senior note issuance on June 17. Analyst sentiment remains broadly constructive but has seen recent moderation; while firms like JP Morgan and Morgan Stanley raised price targets in March, more recent actions in May and July from Mizuho, Barclays, and Citigroup involved slight price target reductions to a range of $35-$38, despite maintaining 'Buy' or 'Overweight' ratings. This collective view, alongside a more cautious 'Equal-Weight' rating from Morgan Stanley, indicates a tempered outlook on valuation heading into the earnings announcement from its recent close of $31.55.

Key Decisions for Investors

• Investors should focus on the Q2 earnings call for management's explanation of the divergence between flat year-over-year EPS and projected revenue growth, as this will be key to understanding margin pressures.
• The recent downward, albeit minor, price target revisions from several analysts suggest a more cautious entry point may be prudent, even as consensus targets still imply material upside from the current $31.55 share price.
• The use of proceeds from the $2.0 billion note offering is a critical data point to watch for, as it will signal the firm's capital allocation priorities between growth projects, deleveraging, or shareholder returns.